CERo Therapeutics Holdings Inc CERO

Healthcare Biotechnology

CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.

NDAQ:CERO - Post by User

CERo Therapeutics Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by coolfooldumbguyon Jul 17, 2024 11:05am

83 Views

Post# 36136623

This stock is a good buy

Big buy for me this morning,picked up massive amount of this biotech stock in California,at .197 cents per share,it was beaten up badly during the past year,but it looks like it will be going up from this bottom price,so glta,&do your own work researching it.It was a former SPAC.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario